ARTICLE | Distillery Techniques
Drug platforms
March 7, 2018 12:53 AM UTC
An IL-2/CD122-based signaling system could help increase the efficacy of T cell therapies for cancer without the toxicity of wild-type IL-2. The IL-2/CD122-based signaling system consisted of mutant v...
BCIQ Company Profiles
BCIQ Target Profiles